LU53788A1 - - Google Patents

Info

Publication number
LU53788A1
LU53788A1 LU53788A LU53788A LU53788A1 LU 53788 A1 LU53788 A1 LU 53788A1 LU 53788 A LU53788 A LU 53788A LU 53788 A LU53788 A LU 53788A LU 53788 A1 LU53788 A1 LU 53788A1
Authority
LU
Luxembourg
Application number
LU53788A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU53788A1 publication Critical patent/LU53788A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • A61K31/787Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79Polymers of vinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LU53788A 1966-05-31 1967-05-31 LU53788A1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (cg-RX-API-DMAC10.html) 1966-05-31 1966-05-31

Publications (1)

Publication Number Publication Date
LU53788A1 true LU53788A1 (cg-RX-API-DMAC10.html) 1967-07-31

Family

ID=19796753

Family Applications (1)

Application Number Title Priority Date Filing Date
LU53788A LU53788A1 (cg-RX-API-DMAC10.html) 1966-05-31 1967-05-31

Country Status (22)

Country Link
US (1) US3557280A (cg-RX-API-DMAC10.html)
JP (1) JPS5010373B1 (cg-RX-API-DMAC10.html)
AT (1) AT272522B (cg-RX-API-DMAC10.html)
BE (1) BE699091A (cg-RX-API-DMAC10.html)
CH (1) CH490087A (cg-RX-API-DMAC10.html)
CS (1) CS151454B2 (cg-RX-API-DMAC10.html)
DE (1) DE1617576C3 (cg-RX-API-DMAC10.html)
DK (1) DK117587B (cg-RX-API-DMAC10.html)
ES (1) ES340956A1 (cg-RX-API-DMAC10.html)
FI (1) FI43622B (cg-RX-API-DMAC10.html)
FR (1) FR5953M (cg-RX-API-DMAC10.html)
GB (1) GB1131007A (cg-RX-API-DMAC10.html)
GR (1) GR33861B (cg-RX-API-DMAC10.html)
IL (1) IL28009A (cg-RX-API-DMAC10.html)
IT (1) IT1140250B (cg-RX-API-DMAC10.html)
LU (1) LU53788A1 (cg-RX-API-DMAC10.html)
MY (1) MY7100015A (cg-RX-API-DMAC10.html)
NL (1) NL6607516A (cg-RX-API-DMAC10.html)
NO (1) NO126298B (cg-RX-API-DMAC10.html)
SE (1) SE354417B (cg-RX-API-DMAC10.html)
SU (1) SU510986A3 (cg-RX-API-DMAC10.html)
YU (1) YU31326B (cg-RX-API-DMAC10.html)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5418330B2 (cg-RX-API-DMAC10.html) * 1973-03-16 1979-07-06
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US3929989A (en) * 1974-06-14 1975-12-30 Wendt Lab Inc Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
GB1592053A (en) * 1976-12-16 1981-07-01 Norbrook Lab Ltd Oxytetracycline compositions
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
JP5093953B2 (ja) 1999-09-14 2012-12-12 トラスティーズ オブ タフツ カレッジ 遷移金属を用いた化学反応による置換テトラサイクリンの調製方法
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
WO2001052858A1 (en) * 2000-01-24 2001-07-26 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
US6818634B2 (en) * 2000-03-31 2004-11-16 Paratek Pharmaceuticals, Inc. 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
WO2001087824A2 (en) 2000-05-15 2001-11-22 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
US20020128238A1 (en) * 2000-06-16 2002-09-12 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
ATE504562T1 (de) 2000-07-07 2011-04-15 Tufts College 7-, 8- und 9-substitutierte tetracyclinverbindungen
CZ2003343A3 (cs) 2000-07-07 2003-05-14 Trustees Of Tufts College 7-Substituované tetracyklinové sloučeniny
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
EA013908B1 (ru) 2000-07-07 2010-08-30 Трастис Оф Тафтс Коллидж Замещенные соединения миноциклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния млекопитающего
KR20030017609A (ko) 2000-07-07 2003-03-03 트러스티즈 오브 터프츠 칼리지 13-치환된 메타사이클린 화합물
EP2298732A1 (en) 2001-03-13 2011-03-23 Paratek Pharmaceuticals, Inc. 7,9-Substituted tetracycline compounds
AU2002250331A1 (en) * 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
WO2002072031A2 (en) 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
WO2002072022A2 (en) * 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
JP2004529927A (ja) 2001-04-24 2004-09-30 パラテック ファーマシューティカルズ, インク. マラリアの治療のための置換されたテトラサイクリン化合物
EP2311798A1 (en) * 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
JP2005526754A (ja) 2002-03-08 2005-09-08 パラテック ファーマシューティカルズ インコーポレイテッド アミノメチル置換されたテトラサイクリン化合物
CN1653037A (zh) 2002-03-21 2005-08-10 帕拉特克药品公司 取代的四环素化合物
EA200900540A1 (ru) 2002-07-12 2009-12-30 Пэрэтек Фамэсьютикэлс, Инк. Замещённые соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
AU2003287218C1 (en) 2002-10-24 2010-07-15 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
WO2004071490A1 (en) * 2003-02-12 2004-08-26 R & P Korea Co., Ltd. Solvent system of hardly soluble drug with improved elution rate
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
CA2531732C (en) 2003-07-09 2012-04-10 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
EP2295404A3 (en) 2003-07-09 2011-05-11 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
WO2005070878A1 (en) * 2004-01-15 2005-08-04 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
AU2005299294B2 (en) 2004-10-25 2012-06-07 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
EP2284151A3 (en) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
AU2006210406C1 (en) 2005-02-04 2013-03-07 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
DE102005012595A1 (de) * 2005-03-18 2006-09-21 Lanxess Deutschland Gmbh Herstellung von Tri(chlorpropyl)phosphat
JP2009502809A (ja) * 2005-07-21 2009-01-29 パラテック ファーマシューティカルズ インコーポレイテッド 10−置換テトラサイクリンおよびその使用方法
BRPI0617258A2 (pt) * 2005-09-19 2011-07-19 Albemarle Corparation soluções aquosas escoáveis altamente concentradas de ibuprofeno de potássio suas preparações e seus usos
AU2007208214B2 (en) 2006-01-24 2013-02-14 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
US20070244335A1 (en) * 2006-04-17 2007-10-18 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
DE202007019460U1 (de) * 2006-04-24 2012-10-24 Teva Pharmaceutical Industries Ltd. Kristalline Tigecyclin-Formen
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
WO2007133797A2 (en) * 2006-05-15 2007-11-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
US8440646B1 (en) 2006-10-11 2013-05-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of Bacillus anthracis infections
AU2007338681B2 (en) 2006-12-21 2013-09-26 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
EP3812372A3 (en) 2006-12-21 2021-06-30 Paratek Pharmaceuticals, Inc. 7-heterocyclyl substituted sancycline derivatives for treating bacterial, viral and parasitic infections (e.g. malaria) or inflammatory diseases
AU2008239606A1 (en) * 2007-04-12 2008-10-23 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
AU2008246119A1 (en) * 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
ES2386926T3 (es) 2007-07-06 2012-09-06 Paratek Pharmaceuticals, Inc. Métodos para sintetizar minociclina9-sustituida
AU2009220171A1 (en) 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
JP2011517697A (ja) * 2008-04-14 2011-06-16 パラテック ファーマシューティカルズ インコーポレイテッド 置換テトラサイクリン化合物
TW202332671A (zh) 2008-05-19 2023-08-16 美商Prtk Spv2公司 四環素化合物之甲苯磺酸鹽及同素異形體
WO2010011522A1 (en) * 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CA2737470A1 (en) * 2008-09-19 2010-03-25 Paratek Pharmaceuticals, Inc. Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment
DE202010018378U1 (de) 2009-04-10 2016-04-07 Tufts Medical Center, Inc. PAR-1-Aktivierung durch Metalloproteinase-1 (MMP-1)
SI2707003T1 (sl) 2011-05-12 2019-10-30 Paratek Pharm Innc Kristalinične soli amida (4S,4AS,5AR,12AS)-4-dimetilamino-3,10,12,12A-tetrahidroksi-7-((metoksi (metil)amino)-metil)-1,11-diokso-1,4,4A,5,5A,6,11,12A-oktahidro-naftacen -2-karboksilne kisline in postopki za uporabo le-teh
AU2017353588B2 (en) 2016-11-01 2022-07-14 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and use thereof in treating Community-Acquired Bacterial Pneumonia (CABP)
WO2019016609A1 (en) 2017-07-21 2019-01-24 Allergan Pharmaceuticals International Limited TREATMENT OF NON-INFLAMMATORY LESIONS

Also Published As

Publication number Publication date
NO126298B (cg-RX-API-DMAC10.html) 1973-01-22
ES340956A1 (es) 1968-06-16
YU31326B (en) 1973-04-30
DK117587B (da) 1970-05-11
IT1140250B (it) 1986-09-24
BE699091A (cg-RX-API-DMAC10.html) 1967-11-27
FR5953M (cg-RX-API-DMAC10.html) 1968-04-16
DE1617576C3 (de) 1980-12-11
US3557280A (en) 1971-01-19
SU510986A3 (ru) 1976-04-15
FI43622B (cg-RX-API-DMAC10.html) 1971-02-01
DE1617576B2 (de) 1980-04-10
SE354417B (cg-RX-API-DMAC10.html) 1973-03-12
GB1131007A (en) 1968-10-16
GR33861B (el) 1968-02-09
CS151454B2 (cg-RX-API-DMAC10.html) 1973-10-19
JPS5010373B1 (cg-RX-API-DMAC10.html) 1975-04-21
AT272522B (de) 1969-07-10
MY7100015A (en) 1971-12-31
IL28009A (en) 1970-08-19
CH490087A (de) 1970-05-15
DE1617576A1 (de) 1972-04-27
NL6607516A (cg-RX-API-DMAC10.html) 1967-12-01

Similar Documents

Publication Publication Date Title
FI43622B (cg-RX-API-DMAC10.html)
AU1534566A (cg-RX-API-DMAC10.html)
AU1141566A (cg-RX-API-DMAC10.html)
AU417216B2 (cg-RX-API-DMAC10.html)
AU1144366A (cg-RX-API-DMAC10.html)
AU1393566A (cg-RX-API-DMAC10.html)
AU1111066A (cg-RX-API-DMAC10.html)
BE694111A (cg-RX-API-DMAC10.html)
BE692296A (cg-RX-API-DMAC10.html)
BE694348A (cg-RX-API-DMAC10.html)
BE694316A (cg-RX-API-DMAC10.html)
AU2390066A (cg-RX-API-DMAC10.html)
AU407778B2 (cg-RX-API-DMAC10.html)
BE694258A (cg-RX-API-DMAC10.html)
AU411645B2 (cg-RX-API-DMAC10.html)
BE694205A (cg-RX-API-DMAC10.html)
BE694186A (cg-RX-API-DMAC10.html)
AU1027866A (cg-RX-API-DMAC10.html)
BE626310A (cg-RX-API-DMAC10.html)
BE693999A (cg-RX-API-DMAC10.html)
BE693911A (cg-RX-API-DMAC10.html)
BE693633A (cg-RX-API-DMAC10.html)
BE692480A (cg-RX-API-DMAC10.html)
BE694714A (cg-RX-API-DMAC10.html)
BE692148A (cg-RX-API-DMAC10.html)